Recent Annual Filings for MRNA
Fiscal Year |
Assets |
Revenues |
Costs & Expenses |
Comprehensive Income |
Cash Flow - Operating |
Cash Flow - Financing |
Total Net Cash Flow |
2024 |
$14,142,000,000 |
$3,236,000,000 |
$7,181,000,000 |
$-3,448,000,000 |
$-3,004,000,000 |
$56,000,000 |
$-999,000,000 |
2023 |
$18,426,000,000 |
$6,848,000,000 |
$11,087,000,000 |
$-4,467,000,000 |
$-3,118,000,000 |
$-1,377,000,000 |
$-289,000,000 |
2022 |
$25,858,000,000 |
$19,263,000,000 |
$9,843,000,000 |
$8,016,000,000 |
$4,981,000,000 |
$-3,448,000,000 |
$-3,643,000,000 |
2021 |
$24,669,000,000 |
$18,471,000,000 |
$5,175,000,000 |
$12,175,000,000 |
$13,620,000,000 |
$-873,000,000 |
$4,224,000,000 |
2020 |
$7,336,750,000 |
$803,395,000 |
$1,566,539,000 |
$-745,864,000 |
$2,026,971,000 |
$2,033,193,000 |
$2,388,236,000 |
2019 |
$1,589,422,000 |
$60,209,000 |
$574,925,000 |
$-510,897,000 |
$-458,968,000 |
$51,121,000 |
$-422,792,000 |
2018 |
$1,962,149,000 |
$135,068,000 |
$519,476,000 |
$-384,897,000 |
$-330,865,000 |
$1,226,842,000 |
$523,505,000 |